Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin flushing concentrations in GI cancer surgery
NCT04355273Completed
- Sponsor
- Yangzhou University
- Start
- Jan 2018
- Primary completion
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of heparin (3 arms), sponsored by Yangzhou University. Primary endpoint: Activated Clotting Time. Started Jan 2018; status: completed.
02
Drugs
heparin
Beyond the preview
Go deeper on NCT04355273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355273.